Clinic News

Latest in Cardiology

• Poll: Reimplementing CV Services
  Have you and/or your catheterization laboratory applied any of the following significant measures to optimize through-put and safety during the reimplementation of services?
• Do Women and Men With High Bleeding Risk Have Different Long-Term Outcomes After PCI?
  Women with high bleeding risk should not be denied the benefits of PCI when indicated and bleeding avoidance strategies should be uniformly adopted for all patients, especially in women, according to a study publish May 20 in JAMA Cardiology.
• Medscape and ACC Centers of Excellence
  The ACC has collaborated with Medscape to create two Centers of Excellence on the topics of Cardiovascular Risk Reduction and Heart Failure.
• An Interview With Dr. Srihari S. Naidu (Part 1 of the COVID-19 Interview Series)
  Cardiologists across the United States have experienced a variety of COVID-19 presentations and cardiovascular complications.
• Empagliflozin in Heart Failure: Diuretic and Cardio-Renal Effects
  What are the acute and intermediate effects of sodium-glucose co-transporter-2 (SGLT-2) inhibitors on natriuresis, volume status, and neurohormonal activation in heart failure (HF) patients?
• Long-Term Outcomes of CABG vs. PCI for LM Disease: A Surgeon's Perspective
  The last several months have witnessed publication of long-term follow-up of major trials for left main (LM) coronary artery disease revascularization.
• Poll Results: COVID-19 Hypercoagulable Complications
  The medical world's understanding of COVID-19 is constantly evolving. This poll was initiated amid the realization that the frequently reported abnormal coagulation profiles of patients with COVID-19 clearly translate into a significant risk for clinical thrombotic events manifested as strokes (often in young persons), peripheral vascular occlusions, deep vein thrombosis, and pulmonary embolus (traditional embolic […]
• TAVR in Bicuspid vs. Tricuspid Aortic Valves in TVT Registry
  How do the 30-day and 1-year outcomes differ for transcatheter aortic valve replacement (TAVR) in patients with bicuspid versus tricuspid aortic valves using a self-expanding prosthesis?
• Ventilation Techniques and Risk for Transmission of COVID-19
  The following are key points to remember from this systematic review of evidence regarding oxygenation approaches in patients with coronavirus infections.
• NCDR Study: Similar Mortality, Stroke Rates in TAVR Patients With Bicuspid vs. Tricuspid Valves
  Patients with a bicuspid aortic valve (BAV) undergoing TAVR have similar 30-day and one-year mortality and stroke rates as patients with a tricuspid aortic valve, according to a study published May 27 in JACC: Cardiovascular Interventions.